BACKGROUND: Diastolic dysfunction is common and associated with higher mortality in the end-stage renal disease (ESRD) population. E/E', a measure derived from tissue Doppler imaging (TDI), is a correlate of left ventricular (LV) filling pressures. E/E' may be viewed as a confirmatory marker of diastolic dysfunction, but it is not routinely used to quantify diastolic dysfunction. Whether E/E' is associated with N-terminal brain natriuretic peptide (NT-proBNP) or high sensitivity troponin T (hs-TnT) in this population is not known. METHODS: We performed echocardiograms and serology prior to the 2nd or 3rd dialysis session of the week on 35 chronic hemodialysis patients. We compared TDI parameters (E/E' and E' alone), traditional categories of diastolic function (normal, impaired, pseudonormal or restrictive), and ejection fraction (EF) as potential predictors of the outcomes NT-proBNP and hs-TnT. RESULTS: Higher E/E' was associated with higher NT-proBNP (rho 0.48, P = 0.004) and hs-TnT (rho 0.37, P = 0.03). EF did not have statistically significant associations with NT-proBNP (rho -0.2, P = 0.4) or hs-TnT (rho -0.24, P = 0.16). As compared to patients with normal diastolic function, those with impaired or pseudonormal filling patterns did not have significantly different levels of NT-proBNP (P = 0.46); patients in traditional categories of worsened diastolic function actually had lower hs-TnT (P = 0.02). The associations of E/E' with higher NT-proBNP and hs-TnT persisted after multivariate adjustment for EF, LV mass, and volume status. CONCLUSIONS: Tissue Doppler imaging may be more useful in evaluating cardiac function than traditional measures of diastolic dysfunction in the ESRD population.
BACKGROUND:Diastolic dysfunction is common and associated with higher mortality in the end-stage renal disease (ESRD) population. E/E', a measure derived from tissue Doppler imaging (TDI), is a correlate of left ventricular (LV) filling pressures. E/E' may be viewed as a confirmatory marker of diastolic dysfunction, but it is not routinely used to quantify diastolic dysfunction. Whether E/E' is associated with N-terminal brain natriuretic peptide (NT-proBNP) or high sensitivity troponin T (hs-TnT) in this population is not known. METHODS: We performed echocardiograms and serology prior to the 2nd or 3rd dialysis session of the week on 35 chronic hemodialysis patients. We compared TDI parameters (E/E' and E' alone), traditional categories of diastolic function (normal, impaired, pseudonormal or restrictive), and ejection fraction (EF) as potential predictors of the outcomes NT-proBNP and hs-TnT. RESULTS: Higher E/E' was associated with higher NT-proBNP (rho 0.48, P = 0.004) and hs-TnT (rho 0.37, P = 0.03). EF did not have statistically significant associations with NT-proBNP (rho -0.2, P = 0.4) or hs-TnT (rho -0.24, P = 0.16). As compared to patients with normal diastolic function, those with impaired or pseudonormal filling patterns did not have significantly different levels of NT-proBNP (P = 0.46); patients in traditional categories of worsened diastolic function actually had lower hs-TnT (P = 0.02). The associations of E/E' with higher NT-proBNP and hs-TnT persisted after multivariate adjustment for EF, LV mass, and volume status. CONCLUSIONS: Tissue Doppler imaging may be more useful in evaluating cardiac function than traditional measures of diastolic dysfunction in the ESRD population.
Authors: S R Ommen; R A Nishimura; C P Appleton; F A Miller; J K Oh; M M Redfield; A J Tajik Journal: Circulation Date: 2000-10-10 Impact factor: 29.690
Authors: Jonas Hallén; Lene Madsen; Søren Ladefoged; Morten W Fagerland; Victor L Serebruany; Stefan Agewall; Dan Atar Journal: Scand J Urol Nephrol Date: 2010-11-22
Authors: Sherif F Nagueh; Christopher P Appleton; Thierry C Gillebert; Paolo N Marino; Jae K Oh; Otto A Smiseth; Alan D Waggoner; Frank A Flachskampf; Patricia A Pellikka; Arturo Evangelisa Journal: Eur J Echocardiogr Date: 2009-03
Authors: Angela Y-M Wang; Mei Wang; Christopher W-K Lam; Iris H-S Chan; Yan Zhang; John E Sanderson Journal: Hypertension Date: 2008-05-12 Impact factor: 10.190
Authors: Christopher R deFilippi; Eric M Thorn; Monica Aggarwal; Abel Joy; Robert H Christenson; Show-Hong Duh; Jean Jeudy; Garth Beache Journal: Am J Cardiol Date: 2007-07-02 Impact factor: 2.778
Authors: Evangelos Giannitsis; Kerstin Kurz; Klaus Hallermayer; Jochen Jarausch; Allan S Jaffe; Hugo A Katus Journal: Clin Chem Date: 2009-12-03 Impact factor: 8.327
Authors: Jasmine Grewal; Robert McKelvie; Eva Lonn; Peter Tait; Jonas Carlsson; Monica Gianni; Christina Jarnert; Hans Persson Journal: Eur J Heart Fail Date: 2008-03 Impact factor: 15.534
Authors: Scott D Solomon; Rajesh Janardhanan; Anil Verma; Mikhail Bourgoun; William L Daley; Das Purkayastha; Yves Lacourcière; Stephen E Hippler; Harold Fields; Tasneem Z Naqvi; Sharon L Mulvagh; J Malcolm O Arnold; James D Thomas; Michael R Zile; Gerard P Aurigemma Journal: Lancet Date: 2007-06-23 Impact factor: 79.321
Authors: LaTonya J Hickson; Sara M Negrotto; Macaulay Onuigbo; Christopher G Scott; Andrew D Rule; Suzanne M Norby; Robert C Albright; Edward T Casey; John J Dillon; Patricia A Pellikka; Sorin V Pislaru; Patricia J M Best; Hector R Villarraga; Grace Lin; Amy W Williams; Vuyisile T Nkomo Journal: J Am Coll Cardiol Date: 2016-03-15 Impact factor: 24.094